share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bruce Gerald W

SEC announcement ·  Jan 31 16:28
Summary by Moomoo AI
Bruce Gerald W, the Chief Executive Officer of Virpax Pharmaceuticals, Inc. (VRPX), was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As the CEO of the company, Bruce Gerald W's transactions are closely watched by investors for insights into executive confidence in the company's performance and prospects.
Bruce Gerald W, the Chief Executive Officer of Virpax Pharmaceuticals, Inc. (VRPX), was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As the CEO of the company, Bruce Gerald W's transactions are closely watched by investors for insights into executive confidence in the company's performance and prospects.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more